NCT01872611View on ClinicalTrials.gov

Nepafenac Once Daily for Macular Edema - Study 2

PHASE3CompletedINTERVENTIONAL
Enrollment

819

Participants

Timeline

Start Date

June 30, 2013

Primary Completion Date

May 31, 2015

Study Completion Date

May 31, 2015

Conditions
Non-Proliferative Diabetic RetinopathyCataract
Interventions
DRUG

Nepafenac Ophthalmic Suspension, 0.3%

OTHER

Vehicle

Inactive ingredients used as placebo comparator

DRUG

Prednisolone acetate

1 drop instilled in the operative eye 4 times daily beginning post-operatively on the day of surgery for the first 2 weeks, followed by 2 times daily for the next 2 weeks

Sponsors

Lead Sponsor

Alcon Research
All Listed Sponsors
lead

Alcon Research

INDUSTRY